← Back to Search

Dental Implant

PrimeTaper EV Implant for Missing Teeth Restoration

N/A
Waitlist Available
Led By Andy Temmerman, Prof.
Research Sponsored by Dentsply Sirona Implants
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
A stable occlusion, i.e. an opposing natural dentition, a crown, an implant-supported fixed or removable prosthesis, a partial removable prosthesis or a full denture
Adult aged 18-75 years.
Must not have
Florid infection
Hemorrhagic diathesis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at date of implant placement (anticipated average 1 month after inclusion).
Awards & highlights
No Placebo-Only Group

Summary

This trial is studying how well the PrimeTaper EV dental implant works for people who need to replace one missing tooth. The implant is placed in the jawbone and acts like a root for the new tooth. Researchers will check after some time to see if the implant is still working well.

Who is the study for?
Adults aged 18-75 needing a single tooth implant in specific positions of the jaw, with stable occlusion and adjacent teeth or crowns. Excludes those allergic to titanium/stainless steel, with uncontrolled oral diseases, bruxism, immunosuppression, recent heavy treatments (chemo/radiation), substance abuse, severe systemic diseases or conditions affecting healing.
What is being tested?
The trial is testing the PrimeTaper EV implant's success rate for single tooth restorations after one year. It aims to assess how well this particular dental implant survives and integrates into the jawbone over time.
What are the potential side effects?
While not explicitly listed in the provided information, common side effects of dental implants can include pain at the implant site, swelling of gums and face, bruising of skin and gums, minor bleeding and infection.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have stable teeth or dental work that allows me to chew properly.
Select...
I am between 18 and 75 years old.
Select...
I am between 18 and 75 years old.
Select...
My dental setup is stable with either natural teeth or dental work.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have an active, severe infection.
Select...
I have a bleeding disorder.
Select...
I am not on medications that could affect healing after surgery.
Select...
I have severe liver problems.
Select...
I am not pregnant or breastfeeding.
Select...
I do not have any health issues that could affect healing after surgery.
Select...
I need bone regeneration in the area planned for an implant.
Select...
I have had chemotherapy within the last 5 years.
Select...
I have not had a heart attack in the last 3 months.
Select...
I have or might have another type of cancer.
Select...
I do not have untreated dental issues like cavities or gum disease.
Select...
My diabetes is not well-managed.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately after implant placement (anticipated average 1 month after inclusion).
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately after implant placement (anticipated average 1 month after inclusion). for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Implant survival, i.e. number of implants in place counted clinically, 1 year after permanent restoration.
Secondary study objectives
Change of implant stability quotient value (ISQ) between implant placement and permanent restoration.
Change of marginal bone level up to 5 years post permanent restoration compared to permanent restoration.
Change of probing pocket depth (PPD) in mm between permanent restoration, and 6 months, 1, 2, 3, 4 and 5 years after permanent restoration.
+8 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Single tooth restorationsExperimental Treatment1 Intervention
A single, open-label group with patients in need of single tooth restorations will receive PrimeTaper EV implant system with diameters 3.6, 4.2, 4.8, 5.4 mm, and lengths 6.5, 8, 9, 11, 13, 15 and 17 mm.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for a partially edentulous jaw include dental implants, such as the PrimeTaper EV implant. These implants act by integrating with the jawbone through a process called osseointegration, where the titanium post of the implant fuses with the bone, providing a stable and durable foundation for single tooth restorations. This stability is crucial for partially edentulous jaw patients as it ensures the restoration functions like a natural tooth, improving chewing efficiency, speech, and overall oral health. Additionally, implants help preserve the jawbone by preventing bone resorption that typically occurs after tooth loss.
Study of the Clinical Efficiency of an Interdisciplinary Approach to the Treatment of Orofacial Pain and Temporomandibular Joint Disorders in Patients with Complete or Partial Edentulism.Treatment planning and sequence for implant therapy in a young adult with generalized aggressive periodontitis.

Find a Location

Who is running the clinical trial?

Dentsply Sirona ImplantsLead Sponsor
62 Previous Clinical Trials
4,483 Total Patients Enrolled
Dentsply Sirona Implants and ConsumablesLead Sponsor
66 Previous Clinical Trials
4,678 Total Patients Enrolled
Andy Temmerman, Prof.Principal InvestigatorKU Leuven

Media Library

PrimeTaper EV implant (Dental Implant) Clinical Trial Eligibility Overview. Trial Name: NCT05315414 — N/A
Partially Edentulous Jaw Research Study Groups: Single tooth restorations
Partially Edentulous Jaw Clinical Trial 2023: PrimeTaper EV implant Highlights & Side Effects. Trial Name: NCT05315414 — N/A
PrimeTaper EV implant (Dental Implant) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05315414 — N/A
Partially Edentulous Jaw Patient Testimony for trial: Trial Name: NCT05315414 — N/A
~20 spots leftby May 2025